Menstruation During a Lifespan: A Qualitative Study of Women's Experiences

Brantelid, Ida Emilie; Nilvér, Helena; Alehagen, Siw

doi:10.1080/07399332.2013.868465

Cited by 75 publications

(98 citation statements)

References 32 publications

(64 reference statements)

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Continuous hormone replacement therapy (HRT) is the usual regimen prescribed in M2F transgender women, but sequential HRT would be more appropriate following UTx in transgender women. Not only is withdrawal bleeding an important sign of graft function, but it is intrinsically part of being female and therefore contributes to gender identity, which may have psychological benefits …”

Section: Hormonal Factorsmentioning

confidence: 99%

Uterine transplantation in transgender women

Jones

Williams

Saso

et al. 2018

BJOG

View full text Add to dashboard Cite

Section: Hormonal Factorsmentioning

confidence: 99%

Uterine transplantation in transgender women

Jones

Williams

Saso

et al. 2018

BJOG

View full text Add to dashboard Cite

“…, Johnston‐Robledo & Chrisler , Brantelid et al . ). Young women and girls find it shameful to be seen with menstrual products (Knútsdóttir & Broddadóttir , Roberts et al .…”

Section: Introductionmentioning

confidence: 97%

“…Although menstruation is a shared experience for most women, it is a subject and a process that historically has been surrounded with secrecy, shame and lack of knowledge. Menstruation has also been used to stigmatize and devalue women (Choi & McKeown 1997, Beausang & Razor 2000, Schooler et al 2005, Johnston-Robledo & Chrisler 2013, Brantelid et al 2014. Young women and girls find it shameful to be seen with menstrual products (Kn utsd ottir & Broddad ottir 1999, Roberts et al 2002, Grose & Grabe 2014 and to be seen to have visibly bled through their clothes (Burrows & Johnson 2005, Fingerson 2005).…”

Section: Introductionmentioning

confidence: 99%

“…Scant knowledge exists on the relationship between menstrual and menarche experiences and objectification. Women's attitudes towards menstruation have been studied in different groups and cultures in an effort to gain an understanding on how they affect women's experience of the menstrual cycle, with several studies indicating that menstrual attitudes shape and control women's behaviour (McPherson & Korfine 2004, Johnston-Robledo & Chrisler 2013, Brantelid et al 2014. Studies that date back to the 1970s have shown that preparations for and experiences of menarche effect the behaviour and the menstrual attitudes of adult women, with negative experiences being associated with negative attitudes (Clarke & Ruble 1978, Brooks-Gunn & Ruble 1982, McPherson & Korfine 2004, Stubbs 2008.…”

Section: Introductionmentioning

confidence: 99%

“…Menstruation is surrounded by a culture of silenceyou have it but you hide itand above any other body function menstruation is to be concealed (Roberts 2004, Erchull 2013, Brantelid et al 2014. This is supported by propositions that menstruation is 'an unnecessary, avoidable, by-product of the human reproductive process' (Coutinho & Segal 1999) (p.163) and also by the promotional literature on extended cycle oral contraception that constructs menstruation as unhealthy, deviant to social norms and in need of suppression (Gunson 2010).…”

Section: Introductionmentioning

confidence: 99%

See 2 more Smart Citations

The role of menstruation in women's objectification: a questionnaire study

Sveinsdóttir

2017

Journal of Advanced Nursing

View full text Add to dashboard Cite

show abstract

Perceived and Objective Fertility Risk Among Female Survivors of Adolescent and Young Adult Cancer

Din,

Singh-Carlson,

Corliss

et al. 2023

JAMA Netw Open

View full text Add to dashboard Cite

ImportanceFertility is important to many survivors of adolescent and young adult (AYA) cancer, yet data on this population’s fertility perceptions and their alignment with objective infertility risk are scant.ObjectiveTo assess whether estimated treatment gonadotoxicity and posttreatment menstrual pattern are associated with higher infertility risk perception.Design, Setting, and ParticipantsThis retrospective cohort study included female young adult survivors of cancer diagnosed between ages 15 and 39 years were recruited between March 25, 2015, and September 24, 2018, from 2 state cancer registries, social media, and clinician referrals to participate in a study of posttreatment ovarian function. Data analysis occurred between March 1 and September 1, 2022.ExposuresParticipants reported their menstrual pattern. Estimated treatment gonadotoxicity was ascertained through medical record review.Main Outcomes and MeasuresParticipants reported infertility risk perception and were categorized as increased risk (feeling less fertile or unable to become pregnant) or no increased risk (feeling more or as fertile) compared with female individuals their age. Objective infertility risk was determined by estimated gonadotoxicity, menstrual pattern, and ovarian reserve testing of self-collected dried blood spots. Multivariable logistic regression identified factors associated with perceived infertility and underestimation or overestimation of infertility risk.ResultsThis study included 785 female participants with a mean (SD) age of 33.2 (4.8) years at enrollment and 25.9 (5.7) years at diagnosis. Most participants self-identified their race and ethnicity as White (585 [74.5%]) and non-Hispanic (628 [78.7%]). Most participants (483 [61.5%]) perceived a higher risk of infertility compared with female participants their age. Prior exposure to moderate- or high-gonadotoxicity treatments was associated with higher odds of perceiving increased infertility risk compared with exposure to low-gonadotoxicity treatments (adjusted odds ratio [AOR], 2.73 [95% CI, 1.87-3.97] and 15.39 [95% CI, 5.52-42.96], respectively). Amenorrhea and irregular cycles were associated with higher odds of perceiving increased infertility risk (AOR, 3.98 [95% CI, 2.13-7.41] and 1.69 [95% CI, 1.19-2.40], respectively). Perceived infertility risk had minimal agreement with objective risk (κ = 0.19). Multiparity (AOR, 4.17 [95% CI, 2.61-6.64]) was associated with increased odds of underestimation, while older age (AOR, 0.94 [95% CI, 0.89-0.98]), endocrine comorbidity (AOR, 0.35 [95% CI, 0.18-0.69]), and prior infertility (AOR, 0.16 [95% CI, 0.07-0.38]) were associated with lower odds of underestimation. Multiparity (AOR, 0.48 [95% CI, 0.27-0.86]), breast cancer (AOR, 0.38 [95% CI, 0.20-0.73]), and skin cancer (AOR, 0.24 [95% CI, 0.11-0.51]) were associated with lower odds of overestimation.Conclusions and RelevanceIn this cohort study, survivors of AYA cancer had high rates of perceiving increased infertility risk but frequently overestimated or underestimated their risk. These findings suggest that counseling on infertility risk throughout survivorship may reduce misalignment between perceptions and actual risk, decrease fertility-related psychological distress, and inform family planning decisions.

show abstract

Menstruation During a Lifespan: A Qualitative Study of Women's Experiences

Cited by 75 publications

References 32 publications

Uterine transplantation in transgender women

Uterine transplantation in transgender women

The role of menstruation in women's objectification: a questionnaire study

Perceived and Objective Fertility Risk Among Female Survivors of Adolescent and Young Adult Cancer

Contact Info

Product

Resources

About